Pharmacologic and Chemical Adjuvants in Tumor Virotherapy
- 22 May 2009
- journal article
- review article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 109 (7), 3125-3140
- https://doi.org/10.1021/cr900048k
Abstract
No abstract availableThis publication has 268 references indexed in Scilit:
- Phase Ib Trial of Oncolytic Herpes Virus G207 Shows Safety of Multiple Injections and Documents Viral ReplicationMolecular Therapy, 2009
- Hypoxia Enhances the Replication of Oncolytic Herpes Simplex VirusMolecular Therapy, 2009
- Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBMMolecular Therapy, 2009
- Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cellsCancer Gene Therapy, 2008
- Oncolytic HSV-1 Infection of Tumors Induces Angiogenesis and Upregulates CYR61Molecular Therapy, 2008
- Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic EffectsMolecular Therapy, 2008
- Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progressionSeminars in Cancer Biology, 2008
- Cyclophosphamide Increases Transgene Expression Mediated by an Oncolytic Adenovirus in Glioma-Bearing Mice Monitored by Bioluminescence ImagingMolecular Therapy, 2006
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsCancer Immunology, Immunotherapy, 2006
- Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generationNature Medicine, 2003